Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum

Tissue Engineering - Part A

Volumn 15, Issue 12, 2009, Pages 3741-3751

  Prins, Henk Jan ^a   Rozemuller, Henk ^a   Vonk Griffioen, Simone ^a   Verweij, Vivienne G M ^a   Dhert, Wouter J A ^a   Slaper Cortenbach, Ineke C M ^a   Martens, Anton C M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BLOOD SUBSTITUTES; BODY FLUIDS; BONE; CALCIUM; CALCIUM PHOSPHATE; FLOATING BREAKWATERS; FLOWCHARTING; GROWTH KINETICS; PLATELETS; TISSUE ENGINEERING;

ADIPOGENIC; ANTIGEN EXPRESSION; BIPHASIC CALCIUM PHOSPHATES; BONE DEFECT; BONE FORMATION; BONE MARROW; BONE TISSUE ENGINEERING; CHONDROGENIC; CULTURE MEDIA; CULTURE TIME; DOUBLINGS; EX VIVO EXPANSION; FETAL BOVINE SERUM; GOOD MANUFACTURING PRACTICES; HISTOMORPHOMETRY; IN-VITRO; IN-VIVO; MESENCHYMAL STROMAL CELLS; NUDE MICE;

CELL CULTURE;

CALCIUM PHOSPHATE; SCAFFOLD PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE GROWTH; CELL CULTURE; CELL DIFFERENTIATION; CELL LYSATE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMPLANTATION; IN VITRO STUDY; MESENCHYME CELL; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE; TISSUE ENGINEERING;

BOVINAE; MUS MUSCULUS;

EID: 72049124020     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0666     Document Type: Article

References (84)

1. Horwitz, E.M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S., and Keating, A. The International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy Position Statement. Cytotherapy 7, 393, 2005.
2. Gimble, J.M., Katz, A.J., and Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 100, 1249, 2007.
3. Campagnoli, C., Roberts, I.A., Kumar, S., Bennett, P.R., Bellantuono, I., and Fisk, N.M. Identification of mesenchy-mal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98, 2396, 2001.
4. In't Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., de Groot-Swings, G.M., Claas, F.H., Fibbe, W.E., and Kanhai, H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22, 1338, 2004.
5. In't Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., Noort, W.A., Claas, F.H., Willemze, R., Fibbe, W.E., and Kanhai, H.H. Amniotic fluid as a novel source of mesen-chymal stem cells for therapeutic transplantation. Blood 102, 1548, 2003.
6. De Coppi, P., Bartsch, G., Jr., Siddiqui, M.M., Xu, T., Santos, C.C., Perin, L., Mostoslavsky, G., Serre, A.C., Snyder, E.Y., Yoo, J.J., Furth, M.E., Soker, S., and Atala, A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25, 100, 2007.
7. Erices, A., Conget, P., and Minguell, J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109, 235, 2000.
8. Bieback, K., Kern, S., Klü ter, H., and Eichler, H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625, 2004.
9. Kögler, G., Sensken, S., Airey, J.A., Trapp, T., Mü schen, M., Feldhahn, N., Liedtke, S., Sorg, R.V., Fischer, J., Rosenbaum, C., Greschat, S., Knipper, A., Bender, J., Degistirici, O., Gao, J., Caplan, A.I., Colletti, E.J., Almeida-Porada, G., Mü ller, H.W., Zanjani, E., and Wernet, P. A new human somatic stem cell from placental cord blood with intrinsic pluripo-tent differentiation potential. J Exp Med 200, 123, 2004.
10. Wang, H.S., Hung, S.C., Peng, S.T., Huang, C.C., Wei, H.M., Guo, Y.J., Fu, Y.S., Lai, M.C., and Chen, C.C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem cells 22, 1330, 2004.
11. Troyer, D.L., and Weiss, M.L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26, 591, 2007.
12. Secco, M., Zucconi, E., Vieira, N.M., Fogaça, L.L., Cerqueira, A., Carvalho, M.D., Jazedje, T., Okamoto, O.K., Muotri, A.R., and Zatz, M. Multipotent stem cells from umbilical cord: cord is richer than blood Stem Cells 26, 146, 2008.
13. Polisetty, N., Fatima, A., Madhira, S.L., Sangwan, V.S., and Vemuganti, G.K. Mesenchymal cells from limbal stroma of human eye. Mol Vis 14, 431, 2008.
14. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97, 13625, 2000.
15. Miura, M., Gronthos, S., Zhao, M., Lu, B., Fisher, L.W., Robey, P.G., and Shi, S. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100, 5807, 2003.
16. Seo, B.M., Miura, M., Gronthos, S., Bartold, P.M., Batouli, S., Brahim, J., Young, M., Robey, P.G., Wang, C.Y., and Shi, S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364, 149, 2004.
17. Jo, Y.Y., Lee, H.J., Kook, S.Y., Choung, H.W., Park, J.Y., Chung, J.H., Choung, Y.H., Kim, E.S., Yang, H.C., and Choung, P.H. Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng 13, 767, 2007.
18. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
19. Maitra, B., Szekely, E., Gjini, K., Laughlin, M.J., Dennis, J., Haynesworth, S.E., and Koç, O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33, 597, 2004.
20. Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Co-meta, A., Egeler, R.M., Locatelli, F., and Fibbe, W.E. Co-transplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110, 2764, 2007.
21. Prather, W.R., Toren, A., and Meiron, M. Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert Opin Biol Ther 8, 1241, 2008.
22. Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., and Ringdén, O. Treatment of severe acute graft-versus-host disease with third party haploiden-tical mesenchymal stem cells. Lancet 363, 1439, 2004.
23. Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L., and Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390, 2006.
24. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Re-mberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., and Ringdén, O. Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579, 2008.
25. Horwitz, E.M., Prockop, D.J., Gordon, P.L., Koo, W.W., Fitzpatrick, L.A., Neel, M.D., McCarville, M.E., Orchard, P.J., Pyeritz, R.E., and Brenner, M.K. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97, 1227, 2001.
26. Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., and Hofmann, T. Isolated al-logeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imper-fecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99, 8932, 2002.
27. Koç, O.N., Day, J., Nieder, M., Gerson, S.L., Lazarus, H.M., and Krivit, W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30, 215, 2002.
28. Baxter, M.A., Wynn, R.F., Deakin, J.A., Bellantuono, I., Edington, K.G., Cooper, A., Besley, G.T., Church, H.J., Wraith, J.E., Carr, T.F., and Fairbairn, L.J. Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. Blood 99, 1857, 2002.
29. Cancedda, R., Giannoni, P., and Mastrogiacomo, M. A tissue engineering approach to bone repair in large animal models and in clinical practice-review. Biomaterials 28, 4240, 2007.
30. Goldstein, S.A., Pravin, P.V., and Moalli, M.R. Perspectives on tissue engineering of bone. Clin Orthop Rel Res 367S, S419, 1999.
31. Schultz, O., Sittinger, M., Haeupl, T., and Burmester, G.R. Emerging strategies of bone and joint repair. Arthritis Res 2, 433, 2000.
32. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
33. Schimming, R., and Schmelzeisen, R. Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg 62, 724, 2004.
34. Meijer, G.J., de Bruijn, J.D., Koole, R., and van Blitterswijk, C.A. Cell-based bone tissue engineering-review. PLoS Med 4, 260, 2007.
35. Ueda, M., Yamada, Y., Kagami, H., and Hibi, H. Injectable bone applied for ridge augmentation and dental implant placement: human progress study. Implant Dent 17, 82, 2008.
36. Uccelli, A., Moretta, L., and Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8, 726, 2008.
37. Selvaggi, T.A., Walker, R.E., and Fleisher, T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89, 776, 1997.
38. Mackensen, A., Dräger, R., Schlesier, M., Mertelsmann, R., and Lindemann, A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 49, 152, 2000.
39. Tuschong, L., Soenen, S.L., Blaese, R.M., Candotti, F., and Muul, L.M. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 13, 1605, 2002.
40. Sundin, M., Ringdén, O., Sundberg, B., Nava, S., Göther-ström, C., and Le Blanc, K. No alloantibodies against mes-enchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92, 1208, 2007.
41. Doucet, C., Ernou, I., Zhang, Y., Llense, J.R., Begot, L., Holy, X., and Lataillade, J.J. Platelet lysates promote mes-enchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205, 228, 2005
42. Mü ller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M.P., Horwitz, E.M., Conte, P., Handgretinger, R., and Do-minici, M. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8, 437, 2006.
43. Bernardo, M.E., Avanzini, M.A., Perotti, C., Cometa, A.M., Moretta, A., Lenta, E., Del Fante, C., Novara, F., de Silvestri, A., Amendola, G., Zuffardi, O., Maccario, R., and Locatelli, F. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211, 121, 2007.
44. Capelli, C., Domenghini, M., Borleri, G., Bellavita, P., Poma, R., Carobbio, A., Micò, C., Rambaldi, A., Golay, J., and In-trona, M. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 40, 785, 2007.
45. Lange, C., Cakiroglu, F., Spiess, A.N., Cappallo-Obermann, H., Dierlamm, J., and Zander, A.R. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213, 18, 2007.
46. Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Ka-shofer, K., Stadelmeyer, E., Drexler, C., Lanzer, G., Linkesch, W., and Strunk, D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436, 2007.
47. Schallmoser, K., Rohde, E., Reinisch, A., Bartmann, C., Thaler, D., Drexler, C., Obenauf, A.C., Lanzer, G., Linkesch, W., and Strunk, D. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C 14, 185, 2008.
48. Eppley, B.L., Woodell, J.E., and Higgins, J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114, 1502, 2004.
49. Whitman, D.H., Berry, R.L., and Green, D.M. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55, 1294, 1997.
50. Anitua, E., Andia, I., Ardanza, B., Nurden, P., and Nurden, A.T. Autologous platelets as a source of proteins for healing and tissue regeneration-review. Thromb Haemost 91, 4, 2004.
51. Eppley, B.L., Pietrzak, W.S., and Blanton, M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 118, 147e, 2006.
52. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
53. Both, S.K., van der Muijsenberg, A.J., van Blitterswijk, C.A., de Boer, J., and de Bruijn, J.D. A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng 13, 3, 2007.
54. Siddappa, R., Martens, A., Doorn, J., Leusink, A., Olivo, C., Licht, R., van Rijn, L., Gaspar, C., Fodde, R., Janssen, F., van Blitterswijk, C., and deBoer, J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formationinvivo. Proc Natl Acad Sci USA 105, 7281, 2008.
55. Siddappa, R., Licht, R., van Blitterswijk, C., and de Boer, J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25, 1029, 2007.
56. Yuan, H., Van Den Doel, M., Li, S., Van Blitterswijk, C.A., De Groot, K., and De Bruijn, J.D. A comparison of the os-teoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med 13, 1271, 2002.
57. von Bonin, M., Stö lzel, F., Goedecke, A., Richter, K., Wu-schek, N., Hölig, K., Platzbecker, U., Illmer, T., Schaich, M., Schetelig, J., Kiani, A., Ordemann, R., Ehninger, G., Schmitz, M., and Bornhäuser, M. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43, 245, 2009.
58. Marcacci, M., Kon, E., Moukhachev, V., Lavroukov, A., Kutepov, S., Quarto, R., Mastrogiacomo, M., and Cancedda, R. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng 13, 947, 2007.
59. Caterson, E.J., Nesti, L.J., Danielson, K.G., and Tuan, R.S. Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol 20, 245, 2002.
60. Shahdadfar, A., Frønsdal, K., Haug, T., Reinholt, F.P., and Brinchmann, J.E. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23, 1357, 2005.
61. Bieback, K., Schallmoser, K., Klu}ter, H., and Strunk, D. Clinical protocols for the isolation and expansion of mesen-chymal stromal cells. Transfus Med Hemother 35, 286, 2008.
62. Lowery, G.L., Kulkarni, S., and Pennisi, A.E. Use of autologous growth factors in lumbar spinal fusion. Bone 25, 47S, 1999.
63. Castelnovo, L., Dosquet, C., Gaudric, A., Sahel, J., and Hicks, D. Human platelet suspension stimulates porcine retinal glial proliferation and migration in vitro. Invest Ophthalmol Vis Sci 41, 601, 2000.
64. van den Dolder, J., Mooren, R., Vloon, A.P., Stoelinga, P.J., and Jansen, J.A. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12, 3067, 2006.
65. Dimarakis, I., and Levicar, N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24, 1407, 2006.
66. Rubio, D., Garcia-Castro, J., Mart́in, M.C., de la Fuente, R., Cigudosa, J.C., Lloyd, A.C., and Bernad, A. Spontaneous human adult stem cell transformation. Cancer Res 65, 3035, 2005.
67. Miura, M., Miura, Y., Padilla-Nash, H.M., Molinolo, A.A., Fu, B., Patel, V., Seo, B.M., Sonoyama, W., Zheng, J.J., Baker, C.C., Chen, W., Ried, T., and Shi, S. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095, 2006.
68. Tolar, J., Nauta, A.J., Osborn, M.J., Panoskaltsis Mortari, A., McElmurry, R.T., Bell, S., Xia, L., Zhou, N., Riddle, M., Schroeder, T.M., Westendorf, J.J., McIvor, R.S., Hogendoorn, P.C., Szuhai, K., Oseth, L., Hirsch, B., Yant, S.R., Kay, M.A., Peister, A., Prockop, D.J., Fibbe, W.E., and Blazar, B.R. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25, 371, 2007.
69. Aguilar, S., Nye, E., Chan, J., Loebinger, M., Spencer-Dene, B., Fisk, N., Stamp, G., Bonnet, D., and Janes, S.M. Murine but not human mesenchymal stem cells generate osteosar-coma-like lesions in the lung. Stem Cells 25, 1586, 2007.
70. Rubio, D., Garcia, S., Paz, M.F., De la Cueva, T., Lopez-Fernandez, L.A., Lloyd, A.C., Garcia-Castro, J., and Bernad, A. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS ONE 3, e1398, 2008.
71. Mendes, S.C., Tibbe, J.M., Veenhof, M., Both, S., Oner, F.C., van Blitterswijk, C.A., and de Bruijn, J.D. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 15, 1123, 2004.
72. Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., and Robey, P.G. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12, 1335, 1997.
73. Mendes, S.C., Tibbe, J.M., Veenhof, M., Bakker, K., Both, S., Platenburg, P.P., Oner, F.C., de Bruijn, J.D., and van Blit-terswijk, C.A. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8, 911, 2002.
74. Braccini, A., Wendt, D., Jaquiery, C., Jakob, M., Heberer, M., Kenins, L., Wodnar-Filipowicz, A., Quarto, R., and Martin, I. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23, 1066, 2005.
75. Kasten, P., Vogel, J., Luginbuhl, R., Niemeyer, P., Weiss, S., Schneider, S., Kramer, M., Leo, A., and Richter, W. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cell Tissues Organs 183, 68, 2006.
76. Vogel, J.P., Szalay, K., Geiger, F., Kramer, M., Richter, W., and Kasten, P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 17, 462, 2006.
77. Haasters, F., Prall, W.W., Anz, D., Bourquin, C., Pautke, C., Endres, S., Mutschler, W., Docheva, D., and Schieker, M. Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat 214, 759, 2009.
78. Deryugina, E.I., Ratnikov, B.I., Bourdon, M.A., and Mü ller-Sieburg, C.E. Clonal analysis of primary marrow stroma: functional homogeneity in support of lymphoid and mye-loid cell lines and identification of positive and negative regulators. Exp Hematol 22, 910, 1994.
79. Yamaguchi, A., and Kahn, A.J. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49, 221, 1991.
80. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., and Deliliers, G.L. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30, 783, 2002.
81. Bü hring, H.J., Battula, V.L., Treml, S., Schewe, B., Kanz, L., and Vogel, W. Novel markers for the prospective isolation of human MSC. Ann NY Acad Sci 1106, 262, 2007.
82. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Pier-santi, S., Saggio, I., Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci, M., and Bianco, P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324, 2007.
83. + cells from culture-expanded mesenchymal stromal cells (MSCs) selects cells with in vivo bone forming capacity. Tissue Eng Part A 14, 730, 2008.
84. Tormin, A., Brune, J.C., Olsson, E., Valcich, J., Neuman, U., Olofsson, T., Jacobsen, S.E., and Scheding, S. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy 11, 114, 2009.